First, do no harm” may be the most well-known adage in the medical profession, but it’s far more than an admonishment. Preventing harm by investing in patient safety is a smart business strategy that ...

Cigna subsidiary Evernorth Health Services is investing $3.5 billion in Shields Health Solutions, a specialty pharmacy company launched after Walgreens went private. Shields partners with more than 80 ...

President Donald Trump’s imposed tariffs on foreign nations have been ruled unlawful by the U.S. Court of Appeals for the Federal Circuit. The court ruled he went too far by declaring national ...

New York City-based Montefiore Health System recorded an operating loss of $17.9 million (-0.4% operating margin) in the first half of 2025, down from an operating income of $32.3 million (0.8% margin ...

Healthcare chaplains, also known as spiritual care providers, can play a key role in advancing hospitals’ and health systems’ strategic priorities. These professionals typically support organizations ...

The FDA has approved Biogen’s Alzheimer’s drug Leqembi for injection to treat individuals with mild cognitive impairment or mild dementia. The drug can now be administered as a once-weekly injection ...

President Donald Trump demanded that pharmaceutical companies release data for “success rates” of their COVID-19 medications to clear up what he called a “discrepancy mess.” In a Sept. 1 Truth Social ...

Beta blockers may provide no clinical benefit to patients who maintain normal heart function following a heart attack, according to a study published Aug. 30 in The New England Journal of Medicine. ...

A new federal rule from HHS that takes effect Oct. 1 is designed to give patients and physicians real-time access to prescription drug costs, insurance coverage details and prior authorization ...

Health systems nationwide are confronting a difficult challenge: surgical demand is rising, but capital and staffing resources for new construction are limited. To meet this challenge, many are ...

Both semaglutide and tirzepatide were shown to “significantly reduce” the risk of hospitalization and all-cause mortality for heart failure patients, according to a study published Aug. 31 in JAMA. ...

CMS on Sept. 2 unveiled policy and operational updates to the Achieving Healthcare Efficiency through Accountable Design Model, a state total cost of care initiative launched in 2023 to curb spending, ...